RoslinCT offers a range of integrated services from GMP translation of research protocols, analytical assay development and process development through to GMP manufacturing and QP batch release of cell-based therapies for clinical trials and commercialisation.

RoslinCT engages with leading cell and gene therapy developers, providing personalised service and driven by the specific individual product requirements. We believe in developing progressive and longstanding collaborations with our clients and aim to provide a bespoke quality service.